Luz M. Baltazar-Rodriguez
University of Colima
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Luz M. Baltazar-Rodriguez.
Gynecologic and Obstetric Investigation | 2008
Iván Delgado-Enciso; Friedman R. Cepeda-Lopez; Elisa A. Monrroy-Guizar; Jose R. Bautista-Lam; Maricela Andrade-Soto; Gregorio Jonguitud-Olguin; Alejandrina Rodríguez-Hernández; Aristoteles Anaya-Ventura; Luz M. Baltazar-Rodriguez; Martha Orozco-Ruiz; Alejandro D. Soriano-Hernández; Iram P. Rodriguez-Sanchez; Ángel Lugo-Trampe; Francisco Espinoza-Gómez; Martha L. Michel-Peregrina
Background:Matrix metalloproteinase-2 (MMP-2) is an enzyme with proteolytic activity on matrix proteins, particularly basement membrane constituents. A single nucleotide polymorphism C>T transition at –1306 displayed a strong association with several cancers. Our study investigated whether or not the MMP-2 –1306C>T polymorphism contributed to the development of breast cancer (BC) in a Mexican population. Methods: 90 patients with BC and 96 control subjects were analyzed to detect MMP-2 –1306C>T polymorphism. Results: The frequency of MMP-2 CC genotype was significantly higher in BC patients when compared with the control group (OR 2.15; 95% CI 1.1–4.1). MMP-2 CC genotype frequency was more pronounced in younger subjects (≤50 years) at diagnosis (OR 2.66; 95% CI 1.04–6.96). Conclusion: The data suggest that MMP-2 –1306C>T polymorphism strongly contributes to the development of BC in the population studied, especially among women 50 years old and younger.
Journal of Genetics | 2009
Iván Delgado-Enciso; Nelida A. Gonzalez-Hernandez; Luz M. Baltazar-Rodriguez; Rebeca O. Millán-Guerrero; Oscar Alberto Newton-Sánchez; Alfonso Bayardo-Noriega; Alfonso Aleman-Mireles; Irma G. Enriquez-Maldonado; Ma J. Anaya-Carrillo; Augusto Rojas-Martinez; Rocio Ortiz-Lopez
1School of Medicine, Universidad de Colima, Av. Universidad 333, Colonia Las Viboras, CP 28040, Colima, Col., Mexico 2General Hospital N◦ 1, Instituto Mexicano del Seguro Social, Colima, Zaragoza 377, Colonia, CP 28040, Mexico 3Hospital Regional Universitario, Secretaria de Salud del Estado de Colima, Km 2.0 Carretcra Colima-Guadalajara, CP 28019, Colima, Mexico 4School of Medicine, Universidad Autonoma de Nuevo Leon, Av. Madero Y Aguirre Peqeno, Mitras Centro, CP 64460, Monterrey Nuevo Leon, Mexico
Archives of Medical Research | 2011
Rebeca O. Millán-Guerrero; Luz M. Baltazar-Rodriguez; Martha I. Cárdenas-Rojas; Mario Ramírez-Flores; Sara Isais-Millán; Iván Delgado-Enciso; Ramiro Caballero-Hoyos; Benjamín Trujillo-Hernández
BACKGROUND AND AIMS Activation of histamine H3 receptors blocks the release of peptides responsible for headache. Our objective was to investigate the association between the genotypes of A280V polymorphism in the H3 receptor and migraine risk. METHODS We evaluated the frequency of the genotypes of A280V, polymorphism A280V and allelic variants of H3 receptor in 147 migraine patients and 186 healthy controls using a PCR-RLFP method. RESULTS V allele frequency was 6.46% and 2.68% for the cases and controls, respectively (p = 0.02) (OR 2.67; 95% CI 1.20-5.93). The frequency of V/V + V/A genotypes was 12.92% in migraine patients, significantly higher when compared to the 3.22% frequency in the control group (p = 0.001) (OR 4.45; 95% CI 1.7-11.46). CONCLUSIONS The results of this study suggest that V-allele genotypes in the H3 receptor gene are related to migraine risk in the Mexican population. We propose the hypothesis that the V-allele genotypes in the H3 receptor gene increase the population of inactive receptors, enhancing the inhibition of the negative feedback mechanism on the H3 receptor and increasing histamine release, which correlates with migraine attacks in susceptible patients. The case-control study reinforces the role of histamine in migraine pathogenesis.
Gynecologic and Obstetric Investigation | 2015
Alejandro D. Soriano-Hernández; Daniela Madrigal-Pérez; Hector R. Galvan-Salazar; Alejandro Arreola-Cruz; Lorena Briseño-Gomez; José Guzmán-Esquivel; Oxana Dobrovinskaya; Agustin Lara-Esqueda; Iram P. Rodriguez-Sanchez; Luz M. Baltazar-Rodriguez; Francisco Espinoza-Gómez; Margarita L. Martinez-Fierro; Luis de-Leon-Zaragoza; Bertha Alicia Olmedo-Buenrostro; Iván Delgado-Enciso
Background/Aims: Breast cancer is the most common gynecologic malignancy known worldwide. The consumption of certain foods may modify the risk for its development. Peanuts and other seeds have shown anticarcinogenic effects in vitro, but there are a few studies that evaluate the effect of their consumption on the development of breast cancer. The aim of the present study was to determine whether there is an association between the consumption of peanuts, walnuts, and almonds and the development of breast cancer. Methods: We analyzed 97 patients presenting with breast cancer and 104 control subjects that did not have the pathology (BIRADS 1-2). An analysis of the main clinical characteristics and lifelong seed consumption was carried out. The association between the consumption of these foods and the risk for breast cancer was estimated by odds ratios and 95% confidence intervals, controlling other risk factors, using the Mantel-Haenszel analysis. Results: The high consumption of peanuts, walnuts, or almonds significantly reduced the risk for breast cancer by 2-3 times. This protective effect was not found with low or moderate seed consumption when compared with null consumption. Conclusions: High consumption of peanuts, walnuts, and almonds appears to be a protective factor for the development of breast cancer.
International Journal of Gynecological Cancer | 2013
Christian Ramos-Flores; Teresa Romero-Gutiérrez; Iván Delgado-Enciso; Gabriela Enríquez Maldonado; Víctor Montaño Plascencia; Oscar F. Vázquez-Vuelvas; Antonio Quintero-Ramos; Roberto Chaparro Mejía; Francisco Espinoza-Gómez; Luz M. Baltazar-Rodriguez; Laura L. Valdez-Velazquez
Introduction The expression of plasminogen activator inhibitor type 1 (PAI-1), vascular endothelial growth factor (VEGF), and transforming growth factor β1 (TGF-β1) participates in the angiogenesis of several cancer types. The goal of this study was to investigate polymorphisms in genes related to angiogenesis (PAI-1-675 4G/5G, VEGF C936T, and TGF-β1 G-800A) to evaluate the risk for developing uterine cervical cancer (UCC). Methods In a case-control study, 100 healthy subjects and 100 patients with UCC from Mexico were included. We determined the genetic profile of the polymorphic markers, which were evaluated by polymerase chain reaction using a sequence-specific primer. Results There was no statistical difference in the allele distribution from the intergroup comparisons of PAI-1 675 4G/5G and VEGF C936T data; however, a significant difference was observed within TGF-β1 G-800A. The linkage disequilibrium analysis revealed that PAI-1 -675 4G and TGF-β1 -800A pair-haplotype was in strong linkage disequilibrium with a significantly increased risk (odds ratio, 3.44; 95% confidence interval, 1.66–7.25) to UCC. Conclusions The polymorphisms in the genes related to angiogenesis -675 4G/5G PAI-1 and G-800A TGF-β1, segregated solely or combined, might contribute to the increased susceptibility to UCC in a Mexican population.
Journal of Stroke & Cerebrovascular Diseases | 2016
Gabriel Ceja-Espiritu; Iván Delgado-Enciso; Mario Ramírez-Flores; José Guzmán-Esquivel; Luz M. Baltazar-Rodriguez
BACKGROUND Lipoprotein lipase (LPL) plays an important role in plasma lipoprotein metabolism and its polymorphisms are possibly implicated in the etiology of ischemic cerebrovascular disease (CVD). The aim of this work was to determine the association of the of D9N, N291S, and T495G polymorphisms of the LPL gene as a risk factor for the development of CVD. METHODS A case-control study was conducted that included 100 patients with CVD and 120 healthy controls. All the subjects were genotyped for the D9N, N291S, and T495G polymorphisms of the LPL gene through polymerase chain reaction-restriction fragment length polymorphism, and the results were analyzed for their association with CVD. RESULTS The D9N genotype was not significantly correlated with CVD; the odds ratio (OR) between the control subjects and CVD patients was .29 (95% confidence interval [CI], .03-2.66; P = .27). The N291S polymorphism was not significantly correlated with CVD either; the OR between the control subjects and CVD patients was 1.2 (95% CI, .07-19.46; P = .89). And the T495G mutation was not significantly correlated with CVD; the OR between the control subjects and the CVD patients was 1.21 (95% CI, .7-2.08; P = .48). CONCLUSIONS In the present study, the D9N, N291S, and T495G polymorphisms of the LPL gene were not risk factors for the development of CVD.
PLOS ONE | 2014
Eduardo Gómez-Gómez; Martín Efrén Ríos-Martínez; Elena Margarita Castro-Rodríguez; Mario Del-Toro-Equíhua; Mario Ramírez-Flores; Iván Delgado-Enciso; Ana Lilia Pérez-Huitimea; Luz M. Baltazar-Rodriguez; Gilberto Velasco-Pineda; Jesús Muñiz-Murguía
Carnitine palmitoyltransferase IB (CPT1B) and adrenoceptor beta-3 (ADRB3) are critical regulators of fat metabolism. CPT1B transports free acyl groups into mitochondria for oxidation, and ADRB3 triggers lipolysis in adipocytes, and their respective polymorphisms E531K and W64R have been identified as indicators of obesity in population studies. It is therefore important to understand the effects of these mutations on ADRB3 and CPT1B function in adipose and skeletal muscle tissue, respectively. This study aimed to analyze the rate of lipolysis of plasma indicators (glycerol, free fatty acids, and beta hydroxybutyrate) and fat oxidation (through the non-protein respiratory quotient). These parameters were measured in 37 participants during 30 min of aerobic exercise at approximately 62% of maximal oxygen uptake, followed by 30 min of recovery. During recovery, mean respiratory quotient values were higher in K allele carriers than in non-carriers, indicating low post-exercise fatty acid oxidation rates. No significant differences in lipolysis or lipid oxidation were observed between R and W allele carriers of ADRB3 at any time during the aerobic load. The substitution of glutamic acid at position 531 by lysine in the CPT1B protein decreases the mitochondrial beta-oxidation pathway, which increases the non-protein respiratory quotient value during recovery from exercise. This may contribute to weight gain or reduced weight-loss following exercise.
Medicina Clinica | 2017
José C. Tapia-Rivera; Luz M. Baltazar-Rodriguez; Martha I. Cárdenas-Rojas; Alan Álvarez; Rafael Bustos-Saldaña; Iván Delgado-Enciso; Laura L. Valdez-Velazquez; José Guzmán-Esquivel; Mario Ramírez-Flores
BACKGROUND AND OBJECTIVE Obesity is a factor that contributes to the morbidity of certain diseases and to worldwide mortality. MGAT1 is a glycosyltransferase involved in the synthesis of protein-bound and lipid-bound oligosaccharides and its polymorphisms are possibly involved in the etiology of obesity. We investigated the association of the rs4285184 polymorphism of the MGAT1 gene with obesity in adults in the State of Colima, Mexico. METHODS A case-control study was conducted that included 244 subjects. All of them were grouped according to their percentage of body fat, determined through bioelectrical impedance, and they were genotyped for the rs4285184 polymorphism of the MGAT1 gene through PCR-RFLP. The results were analyzed for their association with the percentage of body fat. RESULTS The G allele had a frequency of 49.19 and 38.75% for the cases and controls, respectively (P=.020) (OR 1.53; 95% CI 1.068-2.193). The frequency of the A/G+G/G genotype was 75% in the obese patients, which was significantly higher compared with the 57.5% of the control group (P=.004) (OR 2.217; 95% CI 1.287-3.821). CONCLUSIONS The presence of the rs4285184 polymorphism of the MGAT1 gene increased the risk for developing body fat associated with obesity in the Mexican population.
Biochemical Genetics | 2008
Luz M. Baltazar-Rodriguez; Aristoteles Anaya-Ventura; Maricela Andrade-Soto; Elisa A. Monrroy-Guizar; Jose R. Bautista-Lam; Gregorio Jonguitud-Olguin; Friedman R. Cepeda-Lopez; Veronica A. Centeno-Aguilar; Nelida A. Gonzalez-Hernandez; Alejandro D. Soriano-Hernández; Mario Ramírez-Flores; Ángel Lugo-Trampe; Iram P. Rodriguez-Sanchez; Oscar Alberto Newton-Sánchez; Iván Delgado-Enciso
International Urology and Nephrology | 2012
Alejandro D. Soriano-Hernández; Hector R. Galvan-Salazar; Daniel A. Montes-Galindo; Alejandrina Rodríguez-Hernández; Rafael Martinez-Martinez; José Guzmán-Esquivel; Laura L. Valdez-Velazquez; Luz M. Baltazar-Rodriguez; Francisco Espinoza-Gómez; Augusto Rojas-Martinez; Rocio Ortiz-Lopez; Rafael González-Alvarez; Iván Delgado-Enciso